These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3304242)
1. Initial experience with a new fibrinolytic agent (APSAC) in patients with major pulmonary embolism. Bett JH; Bunce IH; Cade JF; Concannon AJ; Gallus A; Low J Aust N Z J Med; 1987 Feb; 17(1):77-9. PubMed ID: 3304242 [No Abstract] [Full Text] [Related]
2. Thrombolytic treatment of pulmonary embolism with APSAC. Vander Sande J; Bossaert L; Brochier M; Charbonnier B; Serradigmini A; Elias A; Pintens H; Lauwers MC Eur Respir J; 1988 Aug; 1(8):721-5. PubMed ID: 3069487 [TBL] [Abstract][Full Text] [Related]
3. On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921). Matsuo O; Collen D; Verstraete M Thromb Res; 1981 Nov; 24(4):347-58. PubMed ID: 7038976 [No Abstract] [Full Text] [Related]
4. The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. Hillis WS; Hornung RS Eur Heart J; 1985 Nov; 6(11):909-12. PubMed ID: 3908105 [No Abstract] [Full Text] [Related]
5. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent. Anderson JL J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369 [TBL] [Abstract][Full Text] [Related]
6. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study. Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603 [TBL] [Abstract][Full Text] [Related]
7. Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion Study. Hoffmann JJ; Bonnier JJ; de Swart JB; Custers P; Vijgen M Drugs; 1987; 33 Suppl 3():242-6. PubMed ID: 3315602 [TBL] [Abstract][Full Text] [Related]
8. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study. Monassier JP; Hanssen M Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540 [TBL] [Abstract][Full Text] [Related]
10. [Fibrinolysis therapy using APSAC in acute myocardial infarct]. Hochrein H Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790 [No Abstract] [Full Text] [Related]
11. Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Samama M; Conard J; Verdy E; van Dreden P; Nguyen G; Combrisson A; Acar J Drugs; 1987; 33 Suppl 3():268-74. PubMed ID: 3315605 [TBL] [Abstract][Full Text] [Related]
12. Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction. Julian DG; Borthwick LS; Reid D; Jennings KP; Wainwright RJ; Rodger JC; Wood D; Phillips WS Drugs; 1987; 33 Suppl 3():261-7. PubMed ID: 3315604 [TBL] [Abstract][Full Text] [Related]
13. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States. Anderson JL Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584 [TBL] [Abstract][Full Text] [Related]
14. [Fibrinolysis therapy in massive lung embolism. Experiences in 10 patients 1982-1984]. Lohri A; Lämmle B; Marbet GA; Ritz R; Schmitt HE; Duckert F Schweiz Med Wochenschr; 1985 Aug; 115(31-32):1074-9. PubMed ID: 2931800 [TBL] [Abstract][Full Text] [Related]
15. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357 [TBL] [Abstract][Full Text] [Related]
16. Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism. Dupe RJ; English PD; Smith RA; Green J Thromb Haemost; 1984 Apr; 51(2):248-53. PubMed ID: 6234676 [TBL] [Abstract][Full Text] [Related]